S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSEARCA:PBE

Invesco Dynamic Biotechnology & Genome ETF Stock Forecast, Price & News

$66.25
-1.82 (-2.67%)
(As of 12/3/2021 12:00 AM ET)
Add
Today's Range
$65.67
$67.49
50-Day Range
$66.25
$77.31
52-Week Range
$64.34
$84.86
Volume
14,249 shs
Average Volume
7,697 shs
Market Capitalization
$259.04 million
P/E Ratio
N/A
Dividend Yield
0.00%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive PBE News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Dynamic Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Invesco
Fund NameInvesco Dynamic Biotechnology & Genome ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PBE
Inception Date6/23/2005
Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon

Fund Focus

Asset ClassEquity
BenchmarkDynamic Biotechnology & Genome Intellidex Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$266.53 million
Average Daily Volume$8.43 thousand
Discount/Premium-0.10%

ETF Expenses

Management Fee0.50%
Other Expenses0.09%
Total Expenses0.59%
Fee Waiver0.00%
Net Expenses0.59%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerCitadel

Geographic Exposure of PBE

Currency Exposure of PBE

Sector Exposure of PBE

Industry Exposure of PBE













Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Frequently Asked Questions

How has Invesco Dynamic Biotechnology & Genome ETF's stock been impacted by Coronavirus (COVID-19)?

Invesco Dynamic Biotechnology & Genome ETF's stock was trading at $45.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PBE stock has increased by 44.3% and is now trading at $66.25.
View which stocks have been most impacted by COVID-19
.

Who are Invesco Dynamic Biotechnology & Genome ETF's key executives?

Invesco Dynamic Biotechnology & Genome ETF's management team includes the following people:
  • H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer
  • Bruce T. Duncan, Chief Financial Officer, Treasurer
  • Kevin R. Gustafson, Chief Compliance Officer
  • Keith A Ovitt, Secretary
  • Ronn R. Bagge, Trustee
  • Marc M Kole, Trustee
  • D. Mark McMillan, Trustee
  • Philip M. Nussbaum Mba, Trustee
  • Donald H. Wilson, Trustee

What other stocks do shareholders of Invesco Dynamic Biotechnology & Genome ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Mastercard (MA), Momo (MOMO) and ONEOK (OKE).

What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol?

Invesco Dynamic Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE."

Who are Invesco Dynamic Biotechnology & Genome ETF's major shareholders?

Invesco Dynamic Biotechnology & Genome ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (3.88%), Royal Bank of Canada (1.45%), LPL Financial LLC (1.04%), Anfield Capital Management LLC (0.68%), YHB Investment Advisors Inc. (0.54%) and Goldman Sachs Group Inc. (0.34%).

Which major investors are selling Invesco Dynamic Biotechnology & Genome ETF stock?

PBE stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Citigroup Inc., Morgan Stanley, Raymond James & Associates, Citadel Advisors LLC, Neuberger Berman Group LLC, Commonwealth Equity Services LLC, and Stratos Wealth Partners LTD..

Which major investors are buying Invesco Dynamic Biotechnology & Genome ETF stock?

PBE stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Pacific Sun Financial Corp, LPL Financial LLC, Banque Cantonale Vaudoise, Selective Wealth Management Inc., Koshinski Asset Management Inc., Ibex Wealth Advisors, and Raymond James Financial Services Advisors Inc..

How do I buy shares of Invesco Dynamic Biotechnology & Genome ETF?

Shares of PBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invesco Dynamic Biotechnology & Genome ETF's stock price today?

One share of PBE stock can currently be purchased for approximately $66.25.

How much money does Invesco Dynamic Biotechnology & Genome ETF make?

Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of $259.04 million.

What is Invesco Dynamic Biotechnology & Genome ETF's official website?

The official website for Invesco Dynamic Biotechnology & Genome ETF is www.invescopowershares.com.

Where are Invesco Dynamic Biotechnology & Genome ETF's headquarters?

Invesco Dynamic Biotechnology & Genome ETF is headquartered at 301 West Roosevelt Road, WHEATON, IL 60187, United States.

How can I contact Invesco Dynamic Biotechnology & Genome ETF?

Invesco Dynamic Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The company can be reached via phone at +1-800-9830903.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.